A 28-year-old woman with previously treated TB presents with persistent cough and fever. Culture and drug susceptibility testing show resistance to rifampicin, isoniazid, levofloxacin, and amikacin. Which clinical feature is most likely to distinguish her XDR-TB from an MDR-TB patient in terms of treatment response and prognosis?